During the past decade, Richard S. Cherlin, MD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Richard S. Cherlin, MD" #1 sponsor was "AstraZeneca" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Helixmith Co., Ltd." with 1 trials sponsored and "Kowa Research Institute, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Richard S. Cherlin, MD" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Richard S. Cherlin, MD" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Diabetic Neuropathy, Painful" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Richard S. Cherlin, MD" in a lesser frequency.

Most popular intervention types in "Richard S. Cherlin, MD" are "Drug" (12 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AC2993" (2 trials), "bococizumab (PF-04950615)" (2 trials), "AC2993 10.0 mcg" (1 trials) and "AC2993 2.5 mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Richard S. Cherlin, MD" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Richard S. Cherlin, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Richard S. Cherlin, MD, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Richard S. Cherlin, MD, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Richard S. Cherlin, MD has several departments that took part in Clinical trials: "Radiation Oncology Center - Walnut Creek" - 7 trials